TENX - TENAX THERAPEUTICS, INC.
IEX Last Trade
5.69
0.090 1.582%
Share volume: 0
Last Updated: Thu 26 Dec 2024 08:21:29 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$5.60
0.09
1.61%
Fundamental analysis
26%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
26%
Performance
5 Days
2.91%
1 Month
9.28%
3 Months
63.77%
6 Months
82.85%
1 Year
-75.74%
2 Year
-96.93%
Key data
Stock price
$5.69
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.02 - $26.36
52 WEEK CHANGE
-$78.60
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Christopher T. Giordano
Region: US
Website: tenaxthera.com
Employees: 9
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: tenaxthera.com
Employees: 9
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Tenax Therapeutics, Inc. engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company was founded in 1967 and is headquartered in Morrisville, North Carolina.
Recent news